Wildcat Capital Management’s NantHealth, Inc NH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,458
Closed -$84K 35
2019
Q4
$84K Hold
5,458
0.02% 30
2019
Q3
$59K Hold
5,458
0.03% 29
2019
Q2
$43K Sell
5,458
-7,900
-59% -$80.4K 0.02% 29
2019
Q1
$184K Hold
13,358
0.11% 21
2018
Q4
$109K Hold
13,358
0.07% 20
2018
Q3
$315K Hold
13,358
0.24% 14
2018
Q2
$663K Hold
13,358
0.51% 13
2018
Q1
$611K Hold
13,358
0.5% 13
2017
Q4
$611K Sell
13,358
-2,564
-16% -$136K 0.65% 11
2017
Q3
$984K Hold
15,922
0.18% 15
2017
Q2
$1.01M Hold
15,922
0.27% 14
2017
Q1
$1.18M Hold
15,922
0.38% 12
2016
Q4
$2.37M Buy
15,922
+205
+1% +$36.3K 1.09% 10
2016
Q3
$3.1M Sell
15,717
-326
-2% -$60K 0.93% 13
2016
Q2
$3.01M Buy
+16,043
New +$3.5M 1.13% 10

Other funds holding NH

Wildcat Capital Management's NH Position: Q1 2020 in Review

Wildcat Capital Management sold out of NantHealth, Inc (NH) in Q1 2020, closing a stake of 5,458 shares — an estimated $84K sold.

Wildcat Capital Management first reported a position in NH in Q2 2016 and held it in 15 quarters. The position peaked at $3.1M in Q3 2016. 29 funds tracked by Wall St. Rank hold NH as of Q1 2020.

  • Wildcat Capital Management reported no remaining NantHealth, Inc position as of Q1 2020 after selling out during the quarter.
  • Wildcat Capital Management sold 5,458 NantHealth, Inc shares in Q1 2020, an estimated $84K.
  • Wildcat Capital Management first reported a position in NantHealth, Inc in Q2 2016 and held it in 15 quarters.
  • Wildcat Capital Management's NantHealth, Inc position peaked at $3.1M in Q3 2016.
  • 29 funds tracked by Wall St. Rank held NantHealth, Inc as of Q1 2020.

Based on Wildcat Capital Management's 13F filing for Q1 2020, filed 9 Apr 2020.